Overall, these studies provide evidence of the potential of this new class of photoswitchable compounds, able to synergistically inhibit the two neurodegenerative disease‐related enzymes AChE and MAO‐B, with the added value given by the possibility of photomodulating their pharmacological effect. The gene discussed is MAOB; the disease is neurodegenerative disease.